Home / Stocks / LTGO

LTGO insider trading

Latigo Biotherapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$5.0M
Buys · last 90 days
2 · $5.0M
Most recent buy
2026-08-10

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-10Foresite Capital Fund V, L.P.
10% owner
Bought140,000$18.00$2.5M
2026-08-10Tananbaum James B.
Director · 10% owner
Bought140,000$18.00$2.5M

Most active insider buyers

InsiderRoleBuysTotal bought
Foresite Capital Fund V, L.P.10% owner1$2.5M
Tananbaum James B.Director · 10% owner1$2.5M

See LTGO on the chart

Every insider buy and sell for LTGO plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.